{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-02-01T12:28:19.078813+00:00",
  "news": [
    {
      "title": "Amgen gives up on its once-prized eczema drug - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPV3NpQ3EtcEk3R1Ytdy1DX19ST1J1S2ZUS1FoS2R3MXVmYVpuVzlKdi1XZ2RqU0tfRFlDdjI2elhLd0dJUGtlYkJjYUVsQ3VwbUpDenlXVWlJRmhMbE4zUnVudkpHdU8wZTEwaE1BSjUzell0S09EMHk5RDdyTnpaRFF2TzdIeEMzMlY5ZU0xNTNCTHVSRVVmWUdjWjUtYlA2Q1dJellpb1BkN1ZGaWc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxPV3NpQ3EtcEk3R1Ytdy1DX19ST1J1S2ZUS1FoS2R3MXVmYVpuVzlKdi1XZ2RqU0tfRFlDdjI2elhLd0dJUGtlYkJjYUVsQ3VwbUpDenlXVWlJRmhMbE4zUnVudkpHdU8wZTEwaE1BSjUzell0S09EMHk5RDdyTnpaRFF2TzdIeEMzMlY5ZU0xNTNCTHVSRVVmWUdjWjUtYlA2Q1dJellpb1BkN1ZGaWc?oc=5\" target=\"_blank\">Amgen gives up on its once-prized eczema drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2026-01-30T17:12:48+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Amgen exits $400M autoimmune pact after running vast program - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQX0JJNGxMMTVIY3FndkpvbkJ5WjNaWGhnb3BRNHVLTDk5aFhnM3o4WERSWUVSSTAycm4tTkhOZGhoVGVBVWZSeGpYZmlpNzc0anRrTlRDelh4ZVBYcndEajFLOGhSQlhEZ2VsQTNzRVFYRmhldVBrZVY4U0EtNkU0ZEhaOS1aVktVd0pndHZtR19rNFk3TEVsVkEydEktVzduWUZPOUNjdE9XSHRfbVRUMlRSdzdiaDZtTm5Z?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQX0JJNGxMMTVIY3FndkpvbkJ5WjNaWGhnb3BRNHVLTDk5aFhnM3o4WERSWUVSSTAycm4tTkhOZGhoVGVBVWZSeGpYZmlpNzc0anRrTlRDelh4ZVBYcndEajFLOGhSQlhEZ2VsQTNzRVFYRmhldVBrZVY4U0EtNkU0ZEhaOS1aVktVd0pndHZtR19rNFk3TEVsVkEydEktVzduWUZPOUNjdE9XSHRfbVRUMlRSdzdiaDZtTm5Z?oc=5\" target=\"_blank\">Amgen exits $400M autoimmune pact after running vast program</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2026-01-30T13:55:13+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Amgen Refocuses Pipeline As Rocatinlimab Exit Reshapes Dermatology Outlook - Yahoo! Finance Canada",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQNkQ2SGd3WHpVc2RJTTdlRFczX3ZBcW5tSWxPdWkzdVZURF90LUdBRWNseFEyV25jb29tcWlJSkhJUXY0ZVg2ZXNzRDdTRG5heWltREFHMDZMcDJoSGNkTG5FSTNOV1ZBdG1wSjVNMnZNMWJtVHNERWpSSW94ZkhJSUxCNzh5UTdkMWNpeHp1NUNhNTdqeEE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxQNkQ2SGd3WHpVc2RJTTdlRFczX3ZBcW5tSWxPdWkzdVZURF90LUdBRWNseFEyV25jb29tcWlJSkhJUXY0ZVg2ZXNzRDdTRG5heWltREFHMDZMcDJoSGNkTG5FSTNOV1ZBdG1wSjVNMnZNMWJtVHNERWpSSW94ZkhJSUxCNzh5UTdkMWNpeHp1NUNhNTdqeEE?oc=5\" target=\"_blank\">Amgen Refocuses Pipeline As Rocatinlimab Exit Reshapes Dermatology Outlook</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo! Finance Canada</font>",
      "published": "2026-02-01T10:05:49+00:00",
      "source": "Yahoo! Finance Canada"
    },
    {
      "title": "Atle Fund Management AB Decreases Holdings in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOSDVZbGN0M2lVZURsbTczQmdYQ0dfanE1TnAtRXNrMUdMWVJyM2NMbTBGZ2xiMm5hTkNHbGctUHR2UUN2clNvNDRxcXJXTjFtaUE0bTUwUGpVS2dzaGxoU1hmdHRPUU96bks1RDRNT0hHRjVXX0tCRm5YSW9TaDhNTC1rUnpnaHRWQXI1NmRab2c4LWFRWkM0ZURFdjYtQ3FmQ2xJZjhmZno1aW1qckNVQVdOOERZai1MVlJzdzhn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxOSDVZbGN0M2lVZURsbTczQmdYQ0dfanE1TnAtRXNrMUdMWVJyM2NMbTBGZ2xiMm5hTkNHbGctUHR2UUN2clNvNDRxcXJXTjFtaUE0bTUwUGpVS2dzaGxoU1hmdHRPUU96bks1RDRNT0hHRjVXX0tCRm5YSW9TaDhNTC1rUnpnaHRWQXI1NmRab2c4LWFRWkM0ZURFdjYtQ3FmQ2xJZjhmZno1aW1qckNVQVdOOERZai1MVlJzdzhn?oc=5\" target=\"_blank\">Atle Fund Management AB Decreases Holdings in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-02-01T08:11:17+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "EMA looks into 'data integrity' issue with Amgen's Tavneos - pharmaphorum",
      "link": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQYnpPZlpvSXZkSERkb2o0aWc2RHViZm5TU0x0OTFRZVhEd2hhUjB0OWhaVTdiRlI2VmtkUEVzaTg1aGhIM28yd2Z5bnlrWUg3c1RoT043TUtfdWdmYmY1Qk9pYlFKVzFER2M4VGhCRnZDYU1UUmR3cmhYUXpOcnI0ZA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigAFBVV95cUxQYnpPZlpvSXZkSERkb2o0aWc2RHViZm5TU0x0OTFRZVhEd2hhUjB0OWhaVTdiRlI2VmtkUEVzaTg1aGhIM28yd2Z5bnlrWUg3c1RoT043TUtfdWdmYmY1Qk9pYlFKVzFER2M4VGhCRnZDYU1UUmR3cmhYUXpOcnI0ZA?oc=5\" target=\"_blank\">EMA looks into 'data integrity' issue with Amgen's Tavneos</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">pharmaphorum</font>",
      "published": "2026-01-30T13:44:43+00:00",
      "source": "pharmaphorum"
    },
    {
      "title": "CHMP thumbs-up Novo's semaglutide for MASH, as Amgen gets Tavneos re-review on data integrity concerns - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOSkQ1MlBselFFLWVvdDJKTl9iSGlHZVpUeXd2bTk1X0E4MVFlUGhfVzFuMkkwMDZENTNOYlIzSzBUQlhuRUc1R01EVmtwcmwyLV9acHhGcjdIYllmUHRKVVdyam80RGh1Qjlaclp2MXVBT3QzelFuaUV5OGNfbWw1MkF5NmdiNTNtcENpTXlBUzk0T3pqZ0NDRDdWVklWa1NRcldqZ1Zrckc1Z2RnN1NDS3M4cmZqRm1CTUN1RHVRN3ViOUk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOSkQ1MlBselFFLWVvdDJKTl9iSGlHZVpUeXd2bTk1X0E4MVFlUGhfVzFuMkkwMDZENTNOYlIzSzBUQlhuRUc1R01EVmtwcmwyLV9acHhGcjdIYllmUHRKVVdyam80RGh1Qjlaclp2MXVBT3QzelFuaUV5OGNfbWw1MkF5NmdiNTNtcENpTXlBUzk0T3pqZ0NDRDdWVklWa1NRcldqZ1Zrckc1Z2RnN1NDS3M4cmZqRm1CTUN1RHVRN3ViOUk?oc=5\" target=\"_blank\">CHMP thumbs-up Novo's semaglutide for MASH, as Amgen gets Tavneos re-review on data integrity concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2026-01-30T17:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Amgen backs out of OX40 pact with Kyowa - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE50MXlWeHk5eUl3T09JaGtUSjhaZ1BJQXd5b2ZEdXptVTRMQ3ZzZzZhTFl6MDZnX0hlLU9qVEFzZ1lERUNJSjQzZTJFNjl3bDB0YW5J?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE50MXlWeHk5eUl3T09JaGtUSjhaZ1BJQXd5b2ZEdXptVTRMQ3ZzZzZhTFl6MDZnX0hlLU9qVEFzZ1lERUNJSjQzZTJFNjl3bDB0YW5J?oc=5\" target=\"_blank\">Amgen backs out of OX40 pact with Kyowa</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2026-01-30T17:02:15+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "Sagebrush Lawsuit Tests Amgen 340B Practices And Investor Risk Views - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQTjJwMmdQLU10ZW53Mjdkek1sUUxsNEdpZjl3UlhZRUR2Vm5vX3BiOVNKY3dFRVhwX2ZWQzhLYXBkZU9FQTg2d2docl9BdWx0Q0pSVlJRTVRpM09hTFB4N09ocUUwYUplVlU1blhXX1ZtTGRnVm1iWlZDM0ZRNjhEWjFaZHhiY1NyLWppZ2dLM190Q3JMTmhBMW5nTERnQ2FGMHFOaWJpN0tvSVowMWQxcWUydHphWnRFWFZQSW5nTkNuNzNqazB6SXJDd3pFSDhuOGxBODBR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQTjJwMmdQLU10ZW53Mjdkek1sUUxsNEdpZjl3UlhZRUR2Vm5vX3BiOVNKY3dFRVhwX2ZWQzhLYXBkZU9FQTg2d2docl9BdWx0Q0pSVlJRTVRpM09hTFB4N09ocUUwYUplVlU1blhXX1ZtTGRnVm1iWlZDM0ZRNjhEWjFaZHhiY1NyLWppZ2dLM190Q3JMTmhBMW5nTERnQ2FGMHFOaWJpN0tvSVowMWQxcWUydHphWnRFWFZQSW5nTkNuNzNqazB6SXJDd3pFSDhuOGxBODBR?oc=5\" target=\"_blank\">Sagebrush Lawsuit Tests Amgen 340B Practices And Investor Risk Views</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-01-30T07:40:32+00:00",
      "source": "simplywall.st"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    },
    {
      "title": "Amgen History - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE53MklERTNSbkNVaXhYQ3dPcEtDRU1uTW5mLUdxSGFtZ0wxMmFZSlQ1SnZkY1hZOFZ1RmRsZjNXMGYtM1hQXzl0R0NJSmtQLVJnYzlN?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE53MklERTNSbkNVaXhYQ3dPcEtDRU1uTW5mLUdxSGFtZ0wxMmFZSlQ1SnZkY1hZOFZ1RmRsZjNXMGYtM1hQXzl0R0NJSmtQLVJnYzlN?oc=5\" target=\"_blank\">Amgen History</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2020-12-12T03:24:17+00:00",
      "source": "Amgen"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-01-30",
      "close": 341.8800048828125
    },
    "history": [
      {
        "date": "2026-01-22",
        "close": 347.07000732421875
      },
      {
        "date": "2026-01-23",
        "close": 344.75
      },
      {
        "date": "2026-01-26",
        "close": 349.69000244140625
      },
      {
        "date": "2026-01-27",
        "close": 351.32000732421875
      },
      {
        "date": "2026-01-28",
        "close": 342.2200012207031
      },
      {
        "date": "2026-01-29",
        "close": 342.94000244140625
      },
      {
        "date": "2026-01-30",
        "close": 341.8800048828125
      }
    ],
    "name": "Amgen Inc."
  }
}